Overweight modulates APOE and APOA5 alleles on the risk of severe hypertriglyceridemia

被引:16
|
作者
Lee, Ming-Jen [1 ,2 ]
Chien, Kuo-Liong [3 ,4 ]
Chen, Ming-Fong [3 ]
Stephenson, Dennis A. [5 ]
Su, Ta-Chen [3 ]
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10043, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Med Genet, Taipei 10043, Taiwan
[3] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10043, Taiwan
[4] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10043, Taiwan
[5] McLaughlin Res Inst, Great Falls, MT USA
关键词
Overweight; APOE4; APOA5_T; Genetic polymorphism; Hypertriglyceridemia; APOLIPOPROTEIN-E POLYMORPHISM; A5; GENE; EPSILON-4; ALLELE; ASSOCIATION; LIPOPROTEINS; CHINESE; TRIGLYCERIDE; DISEASE; OBESITY; LIPIDS;
D O I
10.1016/j.cca.2012.10.054
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: This study aimed to investigate whether the body mass index (BMI) in combination with genetic variations in APOE and APOA5_T alleles modulates the risk of sHTG. Methods: There were 255 moderate HTG (TG >= 2.26 and <5.65 mmol/L) and 176 sHTG (TG >= 5.65 mmol/L) and 304 controls (TG<2.26 mmol/L) were recruited. APOE epsilon alleles were genotyped using sequence-specific primers; the APOA5_T allele (c.553G>T, rs2075291) was identified using a restriction site polymorphism. Overweight/obesity was defined as BMI >= 25 kg/m(2) and non-overweight as BMI<25 kg/m(2). Results: Multivariate logistic regression analysis showed, in addition to APOA5_T allele, a significant interaction between BMI >= 25 kg/m(2) and APOE4 carriers on the risk of sHTG. Subjects with diagnosis of diabetes, current smoking, hypertension, levels of non-high density lipoprotein, and BMI >= 25 kg/m(2) were significant determinants of sHTG. The odds ratio (95% confidence intervals) of overweight/obese APOE4 carriers for sHTG was 13.56 (4.89-37.59) more than those of non-overweight non-APOE4 carriers, while the odds ratio for sHTG in overweight/obese patients with the APOA5_T allele was 15.83 (7.77-32.26) higher than those of non-overweight non-APOA5 carriers. Conclusions: Overweight/obesity may potentiate the genetic variants of the APOE4 and APOA5_T alleles on the risk of sHTG. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [21] Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study
    Ariza, Maria-Jose
    Sanchez-Chaparro, Miguel-Angel
    Baron, Francisco-Javier
    Hornos, Ana-Maria
    Calvo-Bonacho, Eva
    Rioja, Jose
    Valdivielso, Pedro
    Gelpi, Jose-Antonio
    Gonzalez-Santos, Pedro
    BMC MEDICAL GENETICS, 2010, 11
  • [22] Resequencing the Apo lipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia
    Evans, D.
    Aberle, J.
    Beil, F. U.
    ATHEROSCLEROSIS, 2011, 219 (02) : 715 - 720
  • [23] Interaction between APOA5-1131T&gt;C and APOE polymorphisms and their association with severe hypertriglyceridemia
    Sousa, Marinez Oliveira
    Alia, Pedro
    Pinto, Xavier
    Corbella, Emili
    Navarro, Miguel-Angel
    CLINICA CHIMICA ACTA, 2008, 395 (1-2) : 68 - 71
  • [24] Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and are positively correlated with the APOA5 S19W polymorphism
    Henneman, P.
    Schaap, F. G.
    Havekes, L. M.
    Rensen, P. C. N.
    Frants, R. R.
    Van Tol, A.
    Hattori, H.
    Smelt, A. H. M.
    Van Dijk, K. Willems
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 506 - 506
  • [25] Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report
    Makhmudova, Umidakhon
    Schulze, P. Christian
    Lorkowski, Stefan
    Maerz, Winfried
    Geiling, J. -A.
    Weingaertner, Oliver
    JOURNAL OF MEDICAL CASE REPORTS, 2024, 18 (01)
  • [26] Mutations in APOA5 or LDLR increase risk of myocardial infarction
    Gregory B. Lim
    Nature Reviews Cardiology, 2015, 12 (2) : 64 - 64
  • [27] APOA5 Q97X Mutation Identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family
    Dussaillant, Catalina
    Serrano, Valentina
    Maiz, Alberto
    Eyheramendy, Susana
    Rodrigo Cataldo, Luis
    Chavez, Matias
    Smalley, Susan V.
    Fuentes, Marcela
    Rigotti, Attilio
    Rubio, Lorena
    Lagos, Carlos F.
    Alfredo Martinez, Jose
    Luis Santos, Jose
    BMC MEDICAL GENETICS, 2012, 13
  • [28] Sex-specific interaction between APOE and APOA5 variants and plasma lipid levels
    Hubacek, J.
    Adamkova, V.
    Lanska, V.
    Skodova, Z.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 486 - 487
  • [29] APOA5 Ala315 &gt;Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels
    Hubacek, Jaroslav A.
    Wang, Wu-Wei
    Skodova, Zdena
    Adamkova, Vera
    Vralik, Michal
    Horinek, Ales
    Stulc, Tomas
    Ceska, Richard
    Talmud, Philippa J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (06) : 773 - 777
  • [30] APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease
    Lee, KWJ
    Ayyobi, AF
    Frohlich, JJ
    Hill, JS
    ATHEROSCLEROSIS, 2004, 176 (01) : 165 - 172